Login
Toggle navigation
Videos
Categories
Trending
Geoff Jamieson, Managing Director of Orcoda Limited (ASX: ODA), discusses the partnership with ShareRing Australia Pty Ltd.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Geoff Jamieson is Mng Dir/CEO at Orcoda Ltd.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Williams Financial, LLC discusses maintaining focus for the new year ahead.
00:10:00
IDM Mining's Red Mountain Gold Project: High-Grade Gold Production and Exploration in Northwestern BC - Insights from the One-to-One Mining Investment Conference in New York
00:10:00
An Entrepreneur's Journey of Strategy Pivots and Perseverance|Stephen Saad, CEO, Aspen Pharmacare Holdings Ltd.
00:10:00
Pictet Asset Management innovates investment strategies; meanwhile, Trump explores limited VP options as hopefuls convene at Mar-a-Lago.
00:10:00
Home Improvement Boom: Insights from Angi CEO Oisin Hanrahan | Oisin Hanrahan, CEO, Angi Inc.
00:10:00
First partner to exceptional teams everywhere|Vas Natarajan,Partner,Accel
00:10:00
From Trading Floors to Humanitarian Shores: The Journey of Paul Kim| CEO, Anapass Inc
00:10:00
Condoleezza Rice Discusses 9/11, Iraq, and Her Career on Uncommon Knowledge
00:10:00
Strategic Insights with Intesa Sanpaolo's CEO on Future Challenges and Opportunities | Carlo Messina, CEO, Intesa Sanpaolo SpA.
00:10:00
CEO David Solomon Highlights Asset and Wealth Management as Key Strategic Opportunity in Discussion on 'Squawk Box' During the Company's Second-Ever Investor Day
00:10:00
Caledonia Mining's Strategic Expansion: Self-Funded Growth and Future Prospects
00:10:00
Geoffrey Benic, CEO of Aleafia Health Inc., and Louis Laflamme, CEO of Opsens Inc., share insights in "The View From The C-Suite."